Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutationsWenxian Wang, Fan Xia, Nan Zheng et al.|The Innovation|2024Cited by 12
Mefatinib as first-line treatment of patients with advanced non–small cell lung cancer harboring rare EGFR mutations.Pingli Wang, Kai Wang, Liming Cao et al.|Journal of Clinical Oncology|2022Cited by 0